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Abstract- The hallmark of vitiligo is the disappearance of melanocytes from the skin. As a result, of 
melanocytes presence in the auditory and vestibular apparatus, the involvement of these systems in vitiligo 
which targets the melanocytes of the whole body is possible; suggesting that vitiligo is a systemic disease 
rather than a purely cutaneous problem. A total of 21 patients with vitiligo were enrolled in this study. A 
group of 20 healthy subjects served as a control group. Pure tone audiometry (PTA), auditory brainstem 
responses (ABR) and vestibular evoked myogenic potentials (VEMP) were carried out in all participants. 
High frequency sensory neural hearing loss was seen in 8 (38.09%) patients. ABR analysis revealed 10 
(47.61%) had an abnormal increase in latency of wave III, and 6 (28.57%) had an abnormal prolongation of 
IPL I-III, however, regarding our VEMP findings, there were no recorded responses on left ear of 1 (4.76%) 
patient and latency of p13 was prolonged in 5(23.80%) patients. There was no correlation between ages, 
duration of disease, and any of the recorded parameters (P>0.05). In the present survey, we highlighted the 
auditory and vestibular involvement in vitiligo patients. 
© 2015 Tehran University of Medical Sciences. All rights reserved.  
Acta Med Iran, 2016;54(2):96-101. 
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Introduction 
 
Vitiligo (leukoderma) is an acquired, sometimes 
familial depigmentary disorder which results from 
selective destruction of melanocytes and characterized 
by pearl-white patches of diverse shapes and sizes, in 
the midst of normally pigmented skin (1-3). 
It affects all races and has no sex prevalence. It has a 
worldwide occurrence of 0.3–1 % (4). 
In Iran, there is no accurate published data; however, 
0.9–1.2 % of the total population has been estimated to 
be suffering from vitiligo (5).  
 As a clinical classification of vitiligo, 7 types have 
been delineated, 1) generalized, 2) focal, 3) segmental, 
4) acrofacial, 5) total, 6) inflammatory and 7) 
occupational (6). 
Under the evolutionary viewpoint, the embryonic 
origin of human melanocytes are from the neural crest, 
and they are located in the epidermis, hair bulbs of the 
skin, the uveal tract, retinal pigment epithelium of the 
eyes, leptomeninges, and the inner ear (4,7). The 
presence of otic melanocytes was described by Alphonse 
Corti (1831) at first (3), and these cells are primarily 
localized throughout the stria vascularis and modiolus of 
the cochlea, but they also exist in the vestibular organs 
(7,8). Melanocytes may have an important role in the 
inner ear since hearing is affected in systemic disorders 
that affect pigmented areas such as the Vogt-Koyanagi 
and Waardenburg syndromes (3). The presence of 
melanocytes is not limited to the peripheral auditory 
system, abnormalities in the brainstem were found in 
both animals and humans with pigment disorders; 
additionally, neurons in the medial superior olivary 
nucleus of albino rabbits were shown to be 24% smaller 
than normal animals, and the branching density of its 
dendrites was significantly reduced (9), so melanocytes 
are also present in the central auditory system. 
 During the recent years, VEMPs have been used to 
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detect vestibular damage. The method was initially 
described by Colebatatch and Halmagyi in 1992 as click 
evoked myogenic potentials (10). The presumed 
pathways of this vestibulocollic reflex start in the 
saccule of the inner ear, continue through the inferior 
vestibular nerve to the vestibular nuclei, the 
vestibulospinal tracts, and the sternocleidomastoid 
muscle (SCM) (11). The saccule has not only anatomic 
proximity to the auditory system but also the great 
similarity between their hair cell ultrastructures, hence, 
assessing subclinical deterioration of the saccular 
neuroepithelium associated with vitiligo became self-
evident.  Evaluation of auditory function in patients with 
vitiligo has been the subject of some studies, and a 
variety of abnormalities was reported. 
To the best of our knowledge, there was no reported 
study considering vestibular evaluation in these patients. 
In this regard, the present study was designed to apply 
conventional pure tone audiometry (PTA) and auditory 
brainstem responses (ABR) to detect any auditory 
involvement; furthermore, vestibular evoked myogenic 
potentials (VEMP) test was achieved in these patients.  
 
Materials and Methods 
 
Subjects 
A case-control study was performed on 21 patients 
with vitiligo (12 females) attending a dermatology clinic 
in a university hospital center, from June 2010 to July 
2011. 
Patients all had a definitive diagnosis of vitiligo 
thorough medical history and clinical examination 
verified by a dermatologist.  
Generalized, focal, segmental, acrofacial, total, 
inflammatory, and occupational vitiligo types were 
encountered in 12 (57.14%), 5 (23.81%), 3 (14.29%), 
0(0%), 1 (4.76%), 0 (0%) and 0 (0%) patients, 
respectively. 
A total of 21 age and sex matched healthy subjects 
(11 females), without any history of auditory and 
vestibular symptoms, participated as a control group. 
The following exclusion criteria for both patient and 
control groups were applied to baseline history of 
familial hearing loss, oral ototoxic drug or corticosteroid 
intake, chronic noise exposure, head trauma, metabolic, 
neurological, vascular and autoimmune disease, any 
systemic disease such as diabetes or hypertension, 
age>46 years and contraindication for VEMP testing 
(e.g. cervical arthritis). 
A questionnaire containing demographic data, 
disease onset as well as the history of auditory and 
vestibular problems was completed for each patient.  
 
Pure tone audiometry 
After otoscopic examination, participants underwent 
audiometric test using a Madsen Orbiter 922 diagnostic 
audiometer (Madsen Electronics, Denmark) at the 
frequencies of 0.25, 0.5, 1.0, 2.0, 4.0 and 8.0 KHz for air 
conduction and between 0.25 and 4.0 KHz for bone 
conduction. Pure Tone Averages (PTA) were calculated 
at frequencies of 0.5, 1 and 2 KHz; normalcy was based 
on the criteria of the American Speech-language-
Hearing Association (ASHA, 1978) for a threshold 
below or equal to 20dBHL (12). 
 
ABR 
ABR was measured using ICS Charter device (GN 
Otometric, Denmark). Three electrodes were placed on 
the vertex (noninverted), the ipsilateral mastoid 
(inverted), and the contralateral mastoid (ground). Inter-
electrode impedance was kept below 5kΩ. The acoustic 
stimuli were rarefaction clicks presented at a repetition 
rate of 13.1/sec, at an intensity of 80dB normal hearing 
level (nHL), with 0.1 ms duration that delivered 
monaurally to TDH 39 earphones. Responses to 2048 
clicks were preamplified and bandpass between 100-
3000 Hz. The analysis time of the screen was 10 ms. 
Duplicate recordings were made to check 
reproducibility. Absolute latency values of waves I, III 
and V and interpeak latencies (IPL) of I-III, III-V, and I-
V, were compared with the results of the control group 
in each ear. 
 
VEMP 
Finally, all candidates underwent the VEMP testing 
with a clinical device of EPIC-Plus (LABAT, Italy). 
During recording, participants were in a sitting position 
with the head rotated away from the stimulated side to 
activate the ipsilateral SCM muscle. Muscle activation 
was monitored via feedback method. The surface 
electrodes were placed as follow: on the upper third of 
SCM as a noninverted electrode, the upper sternum as 
an inverted electrode, and on the forehead as a ground 
electrode. Tone burst of 500Hz was presented at a rate 
of 4.7/sec through an insert receiver. The stimuli 
intensity was 95dBnHL, and an electromyographic 
signal was amplified and bandpass filtered (10-2000 
Hz). The analysis window was 100 ms. Responses to 
150 sweeps were averaged, and the procedure was 
performed twice to ensure reproducibility. The latencies 
of the initial positively (p13) and subsequent negativity 
(n23) were analyzed; VEMP amplitudes corresponded to 
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the p13-n23 interpeak amplitude difference. The 
amplitude ratio (AR) index was calculated according to 
the formula (Ar-Al)/ (Ar+Al) * 100, in which Ar (Al) 
corresponds to stimulation of the right (left) ear. 
 The study protocol was approved by the Ethics 
Committee of Tehran University of Medical Sciences 
while all participants were requested to fill an informed 
consent. 
 
Statistical analysis 
SPSS software, version 11.5 (Chicago, IL, USA) was 
used for statistical evaluation.  
To compare different values between study and 
control groups, non-parametric (Mann-Whitney U-test) 
test was used, since it can be more appropriate for small 
samples and when the normality assumption is not 
satisfied. The criterion for statistical significance was 
defined as P value≤0.05. Pearson’s correlation was used 
to find a significant relation between two numeric 
variables. 
 
Results 
 
Mean (± standard deviation) of age was 30.14 (± 
8.06) years (range, 19-44 years) for patients and 31.19 
(± 7.93) years (range, 18-44 years) for controls. There 
was no statistically significant difference between these 
two groups according to sex and age (P>0.05). 
The mean duration of disease was 9.62 ± 8.37 years 
(range, 0.5-30 years) and nine (42.85%) patients had a 
positive family history of the disease. 
The results of the audiometric test are shown in 
(Table1). Thresholds of audiometry were statistically 
greater in both ears of patients at 2, 4, and 8 KHz 
(P≤0.05).  
 
Table 1. Comparison of Pure tone audiometry results between patient and control 
groups. 
Patient group Control group 
Ear/Frequency(Hz) Mean ± SD(dB) Mean ± SD(dB) P-value 
R250 8.57±3.91       9.04±3.39        0.585 
L250 9.05±4.36 10.01±4.47 0.632 
Total 8.81±4.13 9.51±3.93 0.457 
R500  8.33±2.41 7.23±3.56 0.140 
L500 8.57±3.58 7.61±3.39 0.439 
Total 8.45±2.99 7.42±3.47 0.141 
R1000 8.10±3.34 7.14 ±2.98 0.388 
L1000 7.86±4.05 7.93±2.93 0.599 
Total 7.98±3.69 7.53±2.95 0.751 
R2000 9.76±5.11 6.66±2.41 0.021 
L2000 11.90±9.01 7.14±3.38 0.048 
Total 10.83±7.06 6.90±2.89 0.018 
R4000  17.14±12.50 8.57±4.22 0.005 
L4000 14.76±10.89 8.09±4.02 0.028 
Total 15.95±11.69 8.33±4.12 0.000 
R8000 15.48±11.71 8.30±4.06 0.002 
L8000 18.09±15.36 10.43± 4.74 0.042 
Total 16.78±13.53 9.36±4.40 0.002 
R PTA 8.73±2.16 7.22±2.75 0.058 
L PTA 9.44±3.99 7.59±2.59 0.082 
Total 9.08±3.07 7.40±2.67  
 
 
Abnormal pure tone thresholds were found in 8 
(38.09%) patients including 5 patients with generalized, 
1 with total and 2 with the segmental type of disease, of 
whom three had unilateral, and five had a bilateral 
sensory neural hearing loss. 
Table 2 compares ABR findings of patients and 
controls. A statistically significant increase was found in 
absolute latency of the third peak in right and left ear of 
patients group (P=0.022 and P=0.001, respectively). 
Of 21 patients, 10 (47.61%) had an abnormal 
increase in latency of wave III (greater than 2.5 standard 
deviations from the mean value in normal control 
subjects) and an abnormal increase in IPL of I-III was 
also detected in 6 (28.57%) patients; however, 
differences in other peak latencies and IPLs did not 
reach a statistically significant level. Increase in absolute 
latency of wave III without any changes in absolute 
latency of wave V, as expected, contributes to the 
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decrease in IPL III-V, a finding that was demonstrated 
in 2 (9.25%) patients. 
When considering VEMP results (Table 3), the 
following was evidenced. There was an absent response 
on left ear of 1 (4.76%) patient, latency of p13 was 
significantly prolonged in left ear of our patients in 
comparison with control group (P=0.001), this 
prolongation was noted in 5(23.80%) patients (greater 
than 2.5 standard deviation of the mean value in normal 
control subjects). No differences for the latency of n23 
and the absolute value of amplitude were noted 
(P>0.05). Since the normal value of AR is defined as ≤ 
0.34, 1 (4.76%) patient had abnormal AR, however, it 
was not statistically meaningful (P=0.113), in general, 
7(33.33%) patients had abnormalities in VEMP.  
 
Table 2. Comparison of ABR parameters between 
patient and control groups. 
Patient group(n=21) Control group(n=21) 
Ear/Variable Mean±SD(ms) 
Mean±SD
(ms) 
P-
value 
R/ I Latency 1.50±0.12 1.46±0.10    0.429 
L/ I Latency 1.50±0.13 1.45±0.17 0.193 
R/ III Latency  3.63±0.25 3.62±0.24 0.024 
L/ III Latency 3.62±0.17 3.45±0.10 0.001 
R/ V Latency 5.46±0.26 5.43 ±0.15 0.629 
L/ V Latency    5.44±0.21    5.42±0.15    0.421 
R/IPL I-III Latency 2.18±0.27 1.99±0.13 0.009 
L/IPL I-III Latency 2.11±0.11 2.02±0.17 0.033 
R/IPL III-V Latency 1.83±0.14 1.98±0.13    0.006 
L/IPL III-V Latency 1.82±0.13 1.95±0.16 0.008 
R/IPL I-V Latency 3.96±0.22 3.99±0.58 0.981 
L/IPL I-V Latency 3.93±0.18 3.95±0.19 0.513 
 
 
Table 3. Comparison of VEMP parameters between 
patient and control groups. 
Patient group(n=21) Control group(n=21) 
Ear/Variable Mean ± SD Mean ± SD P-Value 
R/p13 latency(ms)  13.14±1.55 12.79±0.96     0.438 
L/p13 latency(ms)  14.03±1.75 12.96±0.76 0.008 
R/n23 latency(ms)  21.60±1.75 21.96±1.06 0.351 
L/n23 latency(ms)  22.49±1.68 22.40±1.07 0.852 
R/p13-n23 amplitude(µv) 73.97±30.16 75.62±21.08 0.880 
L/p13-n23 amplitude(µv) 77.83±31.64 78.25±18.80    0.933 
AR 0.14±0.11 0.09±0.15 0.117 
 
 
Discussion 
 
Although melanocyte loss in vitiligo is 
predominantly confined to the patient’s skin, alterations 
in the extracutaneous sites have been reported and 
implied sometimes for the inner ear with an associated 
function compromise in this sensory organ (6). The 
exact functions of otic melanocytes are not known; they 
do not appear to be essential for normal hearing. These 
pigments are assumed to play a protective role against 
environmental damage (13). Murillo Cuesta et al., (13) 
stated that, compared to pigmented mice, albino mice 
show a higher prevalence of age-related hearing loss and 
poorer recovery of auditory thresholds after getting 
exposed to noise. 
There are discrepancies in the literature about the 
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influence of vitiligo on auditory thresholds. Some 
authors state that vitiligo influences are hearing 
(3,4,8,9,14–17) whereas others question such influence 
(18–19). 
The hearing loss pattern in present experiment was 
as follows: in 3 (14.28%) patients, loss was in the range 
of 2–8KHz; in 3 (14.28%) patients, it was limited to 4–8 
KHz and in 2 (9.52%) patients, it was limited to 4 KHz 
only. However, pure tone average (PTA) of all patients 
was within the normal range. Current findings 
strengthened the hypothesis that an alteration of the 
inner ear pigment cells might favor the occurrence of 
hypoacusis. 
Some studies were done, which dealt with ABR in 
patients with vitiligo. The sequences of peaks in the 
ABR recording reflect the synaptic activity of 
consecutive nuclei along the afferent in auditory 
pathway in the brainstem. 
Abnormalities of ABR findings in the present study 
consisted of increased wave III latency and IPL I-III. 
Usually, wave III is associated with a neural activity that 
mainly originates from the superior olivary complex 
(SOC) within the brainstem. The increased IPL I-III was 
explained to be due to abnormal synaptic activity and 
transmission of the action potential from the auditory 
nerve to the lower brain stem (4,18). In accordance with 
present results Elsaied et al., (18) noted a statistically 
significant increase of the IPL I-III in patients as 
compared to the controls. Nevertheless, other 
investigators such as Aydoghan et al., (4) found 
statistically significant increase in both ears of the wave 
III latency and IPL I-III and a significant increase of the 
wave V latency in the right ear compared with the 
control; they explained that this finding might be a result 
of delayed synchronization of action potentials in 
brainstem nuclei. These results are in contrast to Shalaby 
et al., (19), who found no statistically significant 
difference between cases and controls in all ABR 
measured parameters and they recommended 
postmortem histopathological studies of the inner ear 
and brainstem to provide more accurate knowledge in 
vitiligo patients. 
There was no correlation between ages, duration of 
disease and wave III and I-III IPL in left ear (P>0.05), 
the same results were confirmed by Elsaied et al., (18) 
and may be explained by that the affection of otic 
melanocytes occurs at the start of the vitiligo and then 
stabilized afterward. 
No study has been encountered in the literature 
addressing vestibular manifestation in vitiligo patients. 
Regarding our VEMP findings, after exclusion of one 
ear with no recorded VEMP, the single abnormality 
index was the statistically significant prolongation of 
p13 on the left ear of our patients (P=0.001). Although 
the mechanism for this abnormality cannot be clearly 
indicated, it seem plausible that melanocytes take part in 
vestibular metabolism through the apparent relationship 
between the dark cells and the adjacent blood vessels; 
and in response to various stressful conditions, these 
cells have been reported to show increased melanin 
synthesis (20,21), additionally, as Wright et al., (22) 
provided evidence in their animal study, posterior-
superior portion of the membranous wall of the saccule 
is lined by melanin and these pigmented cells play an 
active role in regulating endolymph composition which 
has an important role in modulating the vestibular 
stimuli; hence, one can deduce that the increase in 
latency of wave p13 may be due to the disturbance of 
stimuli transduction through inferior vestibular nerve. 
The failure to evidence any amplitude abnormalities 
of VEMP in our survey might be due to the marked 
interindividual variability of amplitude in normal.  
In summary, we have presented evidence implying 
that apart from established auditory involvement in 
vitiligo, as a result of auditory and vestibular 
adjustment, the vestibular system was likely affected by 
the similar condition; however, in our study, the 
auditory involvement is more prominent than the 
vestibular system.  
We recommend that a larger study applying other 
vestibular tests such as video nistagmography (VNG) 
and computerized dynamic posturography (CDP) is 
needed for complete evaluation of the vestibular system 
in these patients.  
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